What are the recommended acute and preventive treatment options for migraine in a low-resource setting?

Treatment of Migraine in Low-Resource Settings

In low-resource settings, start with NSAIDs (ibuprofen, naproxen, or aspirin) or acetaminophen at adequate doses as first-line acute treatment, and if insufficient, add a triptan (sumatriptan being the most cost-effective) to the NSAID or acetaminophen. 1

Acute Treatment Algorithm

Step 1: Initial Treatment for Moderate to Severe Attacks

• First-line: NSAIDs (aspirin, ibuprofen, naproxen) or acetaminophen at appropriate dosing
  • Ensure patients are using adequate doses before declaring treatment failure
  • NSAIDs are particularly cost-effective and widely available 1

Step 2: Escalation if Inadequate Response

• Add a triptan to the NSAID (or to acetaminophen if NSAIDs contraindicated)
  • Sumatriptan is typically the most affordable triptan option
  • The combination of triptan + NSAID is more effective than either alone 1
  • Counsel patients to take medication as early as possible after migraine onset 1

Step 3: For Mild Attacks

• NSAID alone, acetaminophen alone, or their combination is sufficient 1

Step 4: For Severe Nausea/Vomiting

• Add an antiemetic (metoclopramide or domperidone) before or with the analgesic 1, 2
• Consider non-oral triptan formulations if available and affordable

Preventive Treatment (When Needed)

Initiate preventive therapy when patients have frequent attacks (≥4 per month), severe disability despite adequate acute treatment, or contraindications to acute medications. 3

Cost-Effective Preventive Options (in order of priority):

1. Beta-blockers: Propranolol or metoprolol (first choice) 3, 2, 4
2. Antiseizure medications: Topiramate or valproic acid 3, 2, 4
3. Tricyclic antidepressants: Amitriptyline 3, 2
4. Alternative options if above fail:
   • ACE inhibitors (lisinopril)
   • ARBs (candesartan, telmisartan)
   • Flunarizine (where available) 3, 2

Start preventive medications at low doses and titrate gradually over 2-3 months to assess efficacy. 3

Critical Pitfalls to Avoid

Medication Overuse Headache

• Do not use acute medications ≥15 days/month for NSAIDs or ≥10 days/month for triptans 1
• This threshold violation causes medication overuse headache, worsening the condition

Contraindicated Medications

• Never use opioids or butalbital-containing medications for migraine treatment 1
• These provide inferior outcomes and risk dependency

Treatment Timing

• Emphasize taking medication immediately at migraine onset, not waiting for peak severity 1
• Early treatment significantly improves efficacy

Practical Considerations for Low-Resource Settings

The 2024 International Headache Society guidelines specifically categorize recommendations into "optimal" and "essential" levels to accommodate resource-limited settings 5. The essential recommendations align with the stepwise approach above, prioritizing:

• Generic NSAIDs and acetaminophen (universally available and affordable)
• Generic triptans (sumatriptan is off-patent in most regions)
• Generic preventive medications (propranolol, amitriptyline, topiramate)

Cost as a Key Factor

The 2025 ACP guidelines explicitly state that cost should be a primary consideration when selecting among equally effective treatments 1, 3. Prescribe the least expensive option within each therapeutic class.

Lifestyle Modifications (No-Cost Interventions)

Counsel all patients on:

• Adequate hydration
• Regular sleep schedule
• Regular meals
• Stress management techniques
• Identifying and avoiding personal migraine triggers 1, 3

Monitoring and Follow-Up

• Use a headache diary to track attack frequency, medication use, and treatment response 3
• Reassess treatment efficacy after 2-3 months for preventive medications 3
• Switch medications if inadequate response or intolerable side effects occur
• Monitor for medication overuse patterns

Special Populations

Pregnancy and Lactation

• Discuss risks/benefits of all medications 1, 3
• Acetaminophen is generally safest for acute treatment
• Most preventive medications require careful risk-benefit assessment

Treatment Failure

If a patient fails the NSAID + triptan combination and newer agents (gepants, ditans, CGRP antibodies) are unavailable or unaffordable, consider:

• Switching to a different triptan (patients may respond differently to various triptans) 1
• Dihydroergotamine (if available and no vascular contraindications) 1
• Optimizing preventive therapy to reduce attack frequency 3